Chandrasoma D, Chiu S, Niddrie F, Major G
Osteoporos Int. 2024; 35(8):1461-1467.
PMID: 38802556
PMC: 11282122.
DOI: 10.1007/s00198-024-07134-0.
Lane J, Langdahl B, Stone M, Kurth A, Oates M, Timoshanko J
Osteoporos Int. 2024; 35(7):1195-1204.
PMID: 38573517
PMC: 11211143.
DOI: 10.1007/s00198-024-07049-w.
Cia Penoni D, Torres S, Oliveira M, Farias M, Vettore M, Thome Leao A
J Bone Miner Metab. 2023; 41(5):727-737.
PMID: 37432542
DOI: 10.1007/s00774-023-01451-w.
Cia Penoni D, Canellas J, Silami M, Sader F, Pimentel Neto G, Thome Leao A
Arch Endocrinol Metab. 2023; 67(4):e000612.
PMID: 37252700
PMC: 10665075.
DOI: 10.20945/2359-3997000000612.
Qadan L, Ahmed A
Arch Osteoporos. 2023; 18(1):50.
PMID: 37061624
DOI: 10.1007/s11657-023-01244-8.
Defective bone repletion in aged Balb/cBy mice was caused by impaired osteoblastic differentiation.
Sheng M, Lau K, Rundle C, Alsunna A, Wilson S, Baylink D
J Bone Miner Metab. 2022; 40(6):900-913.
PMID: 35947191
PMC: 9722502.
DOI: 10.1007/s00774-022-01361-3.
A retrospective observational study of osteoporosis management after a fragility fracture in primary care.
Bell A, Kendler D, Khan A, Shapiro C M M, Morisset A, Leung J
Arch Osteoporos. 2022; 17(1):75.
PMID: 35513573
PMC: 9072526.
DOI: 10.1007/s11657-022-01110-z.
Cultivating across "pockets of excellence": challenges to sustaining efforts to improve osteoporosis care.
Seaman A, Steffen M, Van Tiem J, Wardyn S, Santana X, Miller K
Osteoporos Int. 2021; 33(1):139-147.
PMID: 34414462
DOI: 10.1007/s00198-021-06098-9.
Long-Term Treatment of Postmenopausal Osteoporosis.
Brown J
Endocrinol Metab (Seoul). 2021; 36(3):544-552.
PMID: 34154042
PMC: 8258325.
DOI: 10.3803/EnM.2021.301.
Fragility fracture identifies patients at imminent risk for subsequent fracture: real-world retrospective database study in Ontario, Canada.
Adachi J, Brown J, Schemitsch E, Tarride J, Brown V, Bell A
BMC Musculoskelet Disord. 2021; 22(1):224.
PMID: 33637078
PMC: 7908684.
DOI: 10.1186/s12891-021-04051-9.
Incorporating Nutrition, Vests, Education, and Strength Training (INVEST) in Bone Health: Trial Design and Methods.
Miller R, Beavers D, Cawthon P, Crotts C, Fanning J, Gerosa J
Contemp Clin Trials. 2021; 104:106326.
PMID: 33631359
PMC: 8180512.
DOI: 10.1016/j.cct.2021.106326.
Approaches to Fracture Risk Assessment and Prevention.
Baim S, Blank R
Curr Osteoporos Rep. 2021; 19(2):158-165.
PMID: 33523422
DOI: 10.1007/s11914-021-00659-x.
Mortality in older adults following a fragility fracture: real-world retrospective matched-cohort study in Ontario.
Brown J, Adachi J, Schemitsch E, Tarride J, Brown V, Bell A
BMC Musculoskelet Disord. 2021; 22(1):105.
PMID: 33485305
PMC: 7824940.
DOI: 10.1186/s12891-021-03960-z.
MicroRNA-197-3p Inhibits the Osteogenic Differentiation in Osteoporosis by Down-Regulating KLF 10.
You M, Zhang L, Zhang X, Fu Y, Dong X
Clin Interv Aging. 2021; 16:107-117.
PMID: 33469278
PMC: 7810594.
DOI: 10.2147/CIA.S269171.
Defining an international cut-off of two-legged countermovement jump power for sarcopenia and dysmobility syndrome.
Hong N, Siglinsky E, Krueger D, White R, Kim C, Kim H
Osteoporos Int. 2020; 32(3):483-493.
PMID: 32894301
PMC: 7929946.
DOI: 10.1007/s00198-020-05591-x.
Public priorities for osteoporosis and fracture research: results from a focus group study.
Hawarden A, Jinks C, Mahmood W, Bullock L, Blackburn S, Gwilym S
Arch Osteoporos. 2020; 15(1):89.
PMID: 32548718
PMC: 7297850.
DOI: 10.1007/s11657-020-00766-9.
Elevated Bone Hardness Under Denosumab Treatment, With Persisting Lower Osteocyte Viability During Discontinuation.
Jahn-Rickert K, Wolfel E, Jobke B, Riedel C, Hellmich M, Werner M
Front Endocrinol (Lausanne). 2020; 11:250.
PMID: 32499755
PMC: 7243474.
DOI: 10.3389/fendo.2020.00250.
Fracture risk following high-trauma versus low-trauma fracture: a registry-based cohort study.
Leslie W, Schousboe J, Morin S, Martineau P, Lix L, Johansson H
Osteoporos Int. 2020; 31(6):1059-1067.
PMID: 32173782
PMC: 7115893.
DOI: 10.1007/s00198-019-05274-2.
Incidence and Mortality of Osteoporotic Refractures in Korea according to Nationwide Claims Data.
Yoo J, Ha Y, Park K, Kim R, Seo S, Koo K
Yonsei Med J. 2019; 60(10):969-975.
PMID: 31538432
PMC: 6753341.
DOI: 10.3349/ymj.2019.60.10.969.
The incidence of hip fracture and mortality rate after hip fracture in Korea: A nationwide population-based cohort study.
Hong S, Han K
Osteoporos Sarcopenia. 2019; 5(2):38-43.
PMID: 31338433
PMC: 6626836.
DOI: 10.1016/j.afos.2019.06.003.